A phase III trial to assess the tolerability and immunogenicity of an influenza A virus vaccine for the treatment of influenza A virus H5N1 subtype.
Phase of Trial: Phase III
Latest Information Update: 11 Jun 2010
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions; Pharmacodynamics; Registrational
- 11 Jun 2010 New trial record